FRENKEL DAN ISRAEL,KOPELEVICH ADI ISRAEL,LIFSHITZ VERONICA ISRAEL,BENROMANO TALI ISRAEL,BORENSTEIN NOFIT ISRAEL
申请号：
IN1641/MUMNP/2011
公开号：
IN2011MN01641A
申请日:
2011.08.08
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
Use of an isolated peptide comprising an amino acid sequence being no more than 25 amino acids in length, the amino acid sequence comprising at least one aspartate or a homolog thereof, the peptide having an Insulin-Degrading Enzyme (IDE) inhibitory activity, for the manufacture of a medicament identified for treating a disease selected from the group consisting of diabetes, obesity, hyperglycemia, retinal damage, renal failure, nerve damage, microvascular damage and varicella-zoster virus (VZV) infection is disclosed.
